Scientists at the University of Cambridge have developed an AI tool using cognitive tests and MRI scans that accurately predicts Alzheimer’s progression, reducing the need for invasive tests and improving early treatment outcomes.
New research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer’s disease.
On Tuesday, January 11, the Centers for Medicare and Medicaid Services (CMS) announced that it proposes to cover U.S. FDA-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease under Coverage with Evidence Development in CMS-approved randomized controlled trials. Here is the SNMMI’s reaction.
West Virginia University scientists have used MRI scans to show what happens when ultrasound waves target a specific area of Alzheimer’s patient’s brains.
Read More
New MRI research has found that being overweight is an additional burden on brain health and it may exacerbate Alzheimer’s disease.
Read More
New MRI research shows that anxiety is associated with an increased rate of progression from mild cognitive impairment to Alzheimer’s disease.
Read MoreFindings based on analysis of MRI and PET scans suggest recurring falls could point to the development of Alzheimer’s Disease in older adults.
Read More
Scientists at the Massachusetts General Hospital have developed a molecular imaging probe to reveal Alzheimer’s disease-related γ-secretase in rodents and macaques with translational potentials in humans.
Read More